Racial differences in sensitivity of blood pressure to aldosterone

Wanzhu Tu1, George J Eckert, Tamara S Hannon

  • 1541 Clinical Dr, CL 365a, Indianapolis, IN 46202-5111. johpratt@iu.edu.

Insights

Black individuals exhibit higher blood pressure (BP) sensitivity to aldosterone, a hormone linked to hypertension risk. This aldosterone sensitivity, not just hormone levels, significantly impacts BP in Black populations.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Racial Health Disparities

Background:

  • Hypertension is more severe in Black populations, with higher complication rates.
  • Sodium retention is implicated in Black hypertension, but mechanisms remain unclear.
  • Aldosterone's role in blood pressure regulation across racial groups requires further investigation.

Purpose of the Study:

  • To investigate the relationship between blood pressure (BP), plasma aldosterone concentration, and plasma renin activity in Black and White children and adults.
  • To examine the effect of simulated hyperaldosteronism on BP responses in different racial groups.

Main Methods:

  • Prospective observational study of 226 Black and 314 White children, with follow-up in adulthood.
  • Analysis of BP, plasma aldosterone, and plasma renin activity.
  • Interventional study administering 9-α fludrocortisone to healthy Black and White adults.

Main Results:

  • Black children and adults showed a positive association between BP and aldosterone concentration, particularly when plasma renin activity was low.
  • This aldosterone-BP relationship was not observed in White participants.
  • Administering 9-α fludrocortisone increased BP in Black adults but not in White adults.

Conclusions:

  • Aldosterone sensitivity is a key determinant of blood pressure in Black individuals.
  • This heightened sensitivity may contribute to hypertension risk in Black populations.
  • Aldosterone sensitivity could be as critical as aldosterone levels in hypertension development.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K